Skip to main content
Johnson & Johnson logo
JNJ.NYSE
Johnson & Johnson
Healthcare · Drug Manufacturers - General

Healthcare conglomerate specializing in pharmaceuticals, medical devices, and consumer health products with trusted global brands.

HQ: United StatesListed: United States

Profile & Fundamentals

Review the profile, reported financial history, AI financial assessment, dividends, splits, and dated events for Johnson & Johnson.

Profile & Fundamentals

Johnson & Johnson Profile & Fundamentals

Examine company identity, ownership, reported performance, valuation, balance-sheet resilience, dividends, buybacks, and material corporate events.

Interactive annual & quarterly chartsAI financial reviewsReported source tables
Explore this pageJump to a Profile & Fundamentals section

Company and Market Context

Company Profile & Ownership

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

JNJ.NYSE

Company profile record

Johnson & Johnson

Common Stock · Healthcare · Drug Manufacturers - General

Official website

Company

Company / asset
Johnson & Johnson
Security type
Common Stock
Sector
Healthcare
Industry
Drug Manufacturers - General
HQ
🇺🇸 United States
Head office
One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933

Leadership & scale

Chief executive
Mr. Joaquin Duato
CEO year born
1963
Full-time employees
138.2K
Fiscal year end
December
IPO date
1944-09-24

Fundamentals snapshot

Updated 2026-07-27
Market Cap
USD 625.5B
P/E
29.7x
Revenue (Q2 26)
USD 25.3B
Profit (Q2 26)
USD 5.5B
Dividend Yield
1.4%
Revenue (FY 25)
USD 94.2B
Shares in public float
2.4B
Insider ownership
0.05%

Reporting & identifiers

Symbol
JNJ.NYSE
Listing
🇺🇸 United States | Dividend Tax: 30%
Ticker Currency
USD
Income Statement Currency
USD
Balance Sheet Currency
USD
Cash Flow Currency
USD
EPS Currency
USD
Contract Type
SPOT
ISIN
US4781601046
Asset ID
equity_c3269539-01b8-5845-8971-363e7e618c20

Ownership

Shares Outstanding

Latest: 2.4B | Max: 2.9B | Min: 2.4B

Shares Outstanding
3.6B2.7B1.8B908.7M0.00
'07
'09
'11
'13
'15
'17
'19
'21
'23
'25
'26

Complete Research Workspace

Unlock the complete Profile & Fundamentals

Sign in to verify your access, or upgrade to the Base plan to open every chart, financial statement, event, and source table.